Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Sale of pharmaceutical products124.96M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
U.S.120.85M96.71%
Other revenue2.1M1.68%
Royalties and milestones2.01M1.61%